STOCK TITAN

Ulta Beauty (ULTA) CLO receives new stock options and restricted share grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ulta Beauty Chief Legal Officer Rene G. Casares received new equity awards in the form of stock options and restricted stock. On March 31, 2026, Casares was granted options to purchase 4,298 shares of Ulta Beauty common stock at an exercise price of $522.71 per share, expiring on March 31, 2036. These options vest in 25% annual increments beginning on March 15, 2027 and on each anniversary through March 15, 2030. Casares also received 1,263 shares of restricted stock that vest 100% on March 15, 2029, increasing direct common stock holdings to 3,116 shares after the grant.

Positive

  • None.

Negative

  • None.
Insider Casares Rene G.
Role Chief Legal Officer
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 4,298 $0.00 --
Grant/Award Common Stock 1,263 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 4,298 shares (Direct); Common Stock — 3,116 shares (Direct)
Footnotes (1)
  1. Represents grant of 1,263 shares of restricted stock, vesting 100% on March 15, 2029. The options, representing an initial right to purchase a total of 4,298 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.
Stock options granted 4,298 shares Grant of stock options on March 31, 2026
Option exercise price $522.71 per share Exercise price for 4,298 stock options
Option expiration March 31, 2036 Expiration date of granted stock options
Restricted stock granted 1,263 shares Restricted stock award on March 31, 2026
Restricted stock vesting date March 15, 2029 100% vesting date for restricted stock
Common shares after grant 3,116 shares Direct Ulta Beauty common stock holdings post-grant
Option vesting schedule 25% annually 2027–2030 Annual vesting from March 15, 2027 to March 15, 2030
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
restricted stock financial
"Represents grant of 1,263 shares of restricted stock, vesting 100% on March 15, 2029."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
vesting financial
"vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-03-31T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Casares Rene G.

(Last)(First)(Middle)
1000 REMINGTON BLVD., SUITE 120

(Street)
BOLINGBROOK ILLINOIS 60440

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Ulta Beauty, Inc. [ ULTA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Legal Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026A1,263(1)A$03,116D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$522.7103/31/2026A4,298 (2)03/31/2036Common Stock4,298$04,298D
Explanation of Responses:
1. Represents grant of 1,263 shares of restricted stock, vesting 100% on March 15, 2029.
2. The options, representing an initial right to purchase a total of 4,298 shares, vesting in 25% annual increments beginning March 15, 2027 and each anniversary thereafter through March 15, 2030.
/s/ Rene G. Casares04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Ulta Beauty (ULTA) disclose in this Form 4 for Rene G. Casares?

Ulta Beauty reported that Chief Legal Officer Rene G. Casares received new equity awards, including stock options and restricted stock. These grants are compensation-related and increase his direct ownership stake in Ulta Beauty common stock.

How many Ulta Beauty (ULTA) stock options were granted to Rene G. Casares?

Rene G. Casares received stock options covering 4,298 shares of Ulta Beauty common stock. These options have an exercise price of $522.71 per share and expire on March 31, 2036, with vesting spread over four annual installments.

What are the vesting terms for Rene G. Casares’s Ulta Beauty stock options?

The options granted to Rene G. Casares vest in 25% annual increments. Vesting begins on March 15, 2027, and continues on each anniversary through March 15, 2030, aligning the award with multi-year service at Ulta Beauty.

What restricted stock did Rene G. Casares receive from Ulta Beauty (ULTA)?

Casares received 1,263 shares of restricted Ulta Beauty common stock. According to the disclosure, these restricted shares vest 100% on March 15, 2029, representing a long-term equity compensation component tied to his continued employment.

How many Ulta Beauty (ULTA) shares does Rene G. Casares own after these grants?

Following the restricted stock grant, Rene G. Casares directly owns 3,116 shares of Ulta Beauty common stock. This reflects his updated direct share position after receiving 1,263 restricted shares as part of his equity compensation package.

Are the Ulta Beauty (ULTA) equity awards to Rene G. Casares open-market purchases?

No. The Form 4 classifies both transactions under code A as grant or award acquisitions. They represent compensation-related stock option and restricted stock grants from Ulta Beauty, not open-market share purchases or sales by Casares.